analyzed the lymphocyte subsets of COVID-19-associated pneumonia and CAP and showed that CD16+CD56+%, CD4+/CD8+ ratio, CD19+, and CD3+CD4+ independently predicted differentiation of COVID-19 and CAP. This evidence concerns the gene CD19 and susceptibility to pneumonia measurement.